πŸ‡ΊπŸ‡Έ FDA
Patent

US 11492350

Compounds and methods of use

granted A61KA61K31/4545A61K31/4709

Quick answer

US patent 11492350 (Compounds and methods of use) held by Tango Therapeutics, Inc. expires Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Tango Therapeutics, Inc.
Grant date
Tue Nov 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/4545, A61K31/4709, A61K31/4725, A61K31/496